STS国家Intermacs数据库持久性左心室辅助装置植入风险模型
本研究基于STS国家Intermacs数据库2019至2023年11342例持久性LVAD植入患者,采用多变量逻辑回归建立90天死亡风险模型,并在时间分割的推导队列(n=6775)和验证队列(n=4567)中评估。O/E分析识别出22家(12.5%)中心死亡率高于预期,14家(8.0%)低于预期。
要点
- 90天死亡率为8.0%,推导队列9.2%高于验证队列7.4%。
- 模型区分度良好,推导队列AUC 0.714,验证队列AUC 0.707。
- 预测风险>0.4时模型高估风险,临床用于高危患者需谨慎。
核心结论
- STS Intermacs风险模型展示满意的区分度和校准度,可用于候选选择、质量改进和提供者绩效评估。
研究设计与样本
- 多变量逻辑回归建模研究,查询STS Intermacs数据库2019年1月至2023年9月原发持久性LVAD植入患者,按时间分为推导队列(2019-2021年植入,n=6775)和验证队列(2022-2023年植入,n=4567)。
主要发现
- 研究人群共11342例,90天死亡率为8.0%,其中推导队列为9.2%,验证队列为7.4%(P=.001)。
- 预测风险>0.4的患者中模型高估风险。
- O/E分析显示22家中心(12.5%)死亡率高于预期(95%CI>1.0),14家中心(8.0%)死亡率低于预期(95%CI<1.0),均P<.05。
临床怎么用
- 该模型可用于LVAD候选患者选择,辅助质量改进和评估中心绩效。
- 对预测风险>0.4的高危患者,模型可能高估风险,临床决策需结合其他信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Statistical risk models for durable left ventricular assist device (LVAD) implantation inform candidate selection, quality improvement, and evaluation of provider performance. This study developed a 90-day mortality risk model using The Society of Thoracic Surgeons National Intermacs Database (STS Intermacs). METHODS: STS Intermacs was queried for primary durable LVAD implants from January 2019 to September 2023. Multivariable logistic regression was used to derive a model based on preimplant risk factors by using derivation (2019-2021 implants) and validation (2022-2023 implants) cohorts. Model performance (derivation and validation cohorts) was assessed using C-statistics, Brier scores, and calibration plots. A refined model (all patients) was generated to calculate observed-to-expected (O/E; 95% CI) ratios for each center. RESULTS: The study population consisted of 11,342 patients from 2019 to 2023 who were sequentially divided in time into derivation (n = 6775) and validation (n = 4567) cohorts. Ninety-day mortality was 8.0% (9.2% in the derivation cohort vs 7.4% in the validation cohort; P = .001). Logistic regression applied to derivation and validation cohorts produced similar discrimination (area under the curve [AUC], 0.714 [95% CI, 0.69-0.74]; and AUC, 0.707; [95% CI, 0.67-0.72], respectively) and calibration (Brier score, .08 vs .07), with overestimation of risk among patients with a predicted risk >0.4. The O/E analysis identified 22 (12.5%) centers with worse than expected mortality with a 95% CI >1.0 and 14 centers (8.0%) with better than expected mortality with a 95% CI <1.0 (all P < .05). CONCLUSIONS: The STS Intermacs risk model demonstrated satisfactory discrimination and calibration. This tool may be used to inform candidate selection, facilitate quality improvement, and assess provider performance.
引用
- Pagani FD, Singletary B, Cantor R, et al. The Society of Thoracic Surgeons National Intermacs Database Risk Model for Durable Left Ventricular Assist Device Implantation. Ann Thorac Surg. 2025. PMID: 39864770. doi:10.1016/j.athoracsur.2024.11.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。